•  
  •  
  •  
  •  

2025-10-06 16:08:48

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025

Keywords Selected:  AmrutanjanHealthCare

Stock Report

  • Amrutanjan Health Care Ltd recommends final dividend of Rs. 2.60
  • Amrutanjan Health Care Ltd Q4FY25 net profit at Rs. 15.17 crores
  • Amrutanjan Health Care Limited to set up new plant for sanitary napkins
  • Amrutanjan Health Care Ltd Q1 FY2024 PAT at Rs. 7.01 crore
  • Amrutanjan Healthcare recognized as Best Healthcare Brand by The Economic Times
  • Amrutanjan Health Care Ltd board approves buyback
  • Amrutanjan Health Care Ltd Q2FY2023 PAT climbs QoQ to Rs. 12.76 crores
  • Amrutanjan Health Care Ltd launches Comfy Period Pain Roll-On
  • Amrutanjan Health Care Limited recommends final dividend of Rs. 2.60
  • Amrutanjan Health Care Ltd Q4 FY2021-22 PAT drops QoQ to Rs. 14.70 crores
  • Amrutanjan Health Care Ltd declares Second Interim Dividend of Rs. 1
  • Amrutanjan Health Care Q3 FY2022 profit increases QoQ to Rs. 20.57 crores
  • Amrutanjan Health Care Ltd Q2FY22 net profit at Rs. 19.84 crore

Latest Post

  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • TVS Motor Company launches most advanced TVS Raider variant
  • Zydus receives final approval from USFDA for Deflazacort oral suspension, 22.75 mg/mL
  • Deepak Group Unveils State-of-the-Art Next-Generation R&D Centre to Pioneer Innovations in Chemistry
  • Smt. Bhuvaneswari Nara selected for IOD's Distinguished Fellowship - 2025


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024